Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

被引：0
|
作者：
Yan-Ye Su
Chih-Yen Chien
Sheng-Dean Luo
Tai-Lin Huang
Wei-Che Lin
Fu-Min Fang
Tai-Jan Chiu
Yen-Hao Chen
Chi-Chih Lai
Cheng-Ming Hsu
Shau-Hsuan Li
机构：
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Otolaryngology
[2] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Hematology
[3] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Oncology
[4] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Diagnostic Radiology
[5] Kaohsiung Chang Gung Memorial Hospital,Department of Radiation Oncology
来源：
World Journal of Surgical Oncology | / 14卷
关键词：
Head and neck cancer; Squamous cell carcinoma; Betel nut; Smoking; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil
    Su, Yan-Ye
    Chien, Chih-Yen
    Luo, Sheng-Dean
    Huang, Tai-Lin
    Lin, Wei-Che
    Fang, Fu-Min
    Chiu, Tai-Jan
    Chen, Yen-Hao
    Lai, Chi-Chih
    Hsu, Cheng-Ming
    Li, Shau-Hsuan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [2] Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil
    Li, Shau-Hsuan
    Lin, Wei-Che
    Huang, Tai-Lin
    Chen, Chang-Han
    Chiu, Tai-Jan
    Fang, Fu-Min
    Huang, Wan-Ting
    Hsu, Cheng-Ming
    Luo, Sheng-Dean
    Lai, Chi-Chih
    Su, Yan-Ye
    Chuang, Hui-Ching
    Chien, Chih-Yen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E844 - E852
  • [3] Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck
    Schultz, J. D.
    Bran, G.
    Anders, C.
    Sadick, H.
    Faber, A.
    Hoermann, K.
    Sauter, A.
    ONCOLOGY REPORTS, 2010, 24 (05) : 1213 - 1216
  • [4] Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma
    Yamauchi, Moriyasu
    Minesaki, Akimichi
    Ishida, Tomoya
    Sato, Yuki
    Okamura, Seiji
    Shuto, Hiroyuki
    Tanaka, Nariyuki
    Hatayama, Eriko
    Shibamiya, Natsuko
    Kuratomi, Yuichiro
    IN VIVO, 2023, 37 (03): : 1275 - 1280
  • [5] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, Felix
    Selzer, Edgar
    Berghold, Andrea
    Reinisch, Sabine
    Kapp, Karin S.
    De Vries, Alexander
    Greil, Richard
    Bachtiary, Barbara
    Tinchon, Christoph
    Anderhuber, Wolfgang
    Burian, Martin
    Kasparek, Anne-Katrin
    Elsaesser, Wolfgang
    Kainz, Herbert
    Riedl, Regina
    Kopp, Michael
    Kornek, Gabriela
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 352 - 359
  • [6] Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
    Takatsugu Mizumachi
    Akihiro Homma
    Tomohiko Kakizaki
    Tomohiro Sakashita
    Satoshi Kano
    Hiromitsu Hatakeyama
    Kazuhiko Tsuchiya
    Koichi Yasuda
    Rikiya Onimaru
    Hiroki Shirato
    Jun Taguchi
    Yasushi Shimizu
    Ichiro Kinoshita
    Hirotoshi Akita
    Satoshi Fukuda
    International Journal of Clinical Oncology, 2015, 20 : 431 - 437
  • [7] Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
    Mizumachi, Takatsugu
    Homma, Akihiro
    Kakizaki, Tomohiko
    Sakashita, Tomohiro
    Kano, Satoshi
    Hatakeyama, Hiromitsu
    Tsuchiya, Kazuhiko
    Yasuda, Koichi
    Onimaru, Rikiya
    Shirato, Hiroki
    Taguchi, Jun
    Shimizu, Yasushi
    Kinoshita, Ichiro
    Akita, Hirotoshi
    Fukuda, Satoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 431 - 437
  • [8] The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
    Kim, Ryul
    Hahn, Seokyung
    Shin, Junghoon
    Ock, Chan-Young
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 907 - 916
  • [9] Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck - The Dana Farber Cancer Institute experience
    Haddad, R
    Colevas, AD
    Tishler, R
    Busse, P
    Goguen, L
    Sullivan, C
    Norris, CM
    Lake-Willcutt, B
    Case, MA
    Costello, R
    Posner, M
    CANCER, 2003, 97 (02) : 412 - 418
  • [10] INDUCTION CHEMOTHERAPY (CISPLATIN+5-FLUOROURACIL) AND RADIOTHERAPY IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    TENNVALL, J
    ALBERTSSON, M
    BIORKLUND, A
    WENNERBERG, J
    ANDERSON, H
    ANDERSSON, T
    ELNER, A
    MERCKE, C
    ACTA ONCOLOGICA, 1991, 30 (01) : 27 - 32
12345